Mabel is a psychedelic-based Women’s health platform that focuses on improving mental well-being through mushroom-based supplements.
Mabel has raised $643K in total funding. The most recent round was Pre-Seed. The last funding was announced in November 2024.
Mabel's investors include Reza Malekzadeh, Jacques-Antoine Granjon, Julian Gray, Jean-Eric Gnuva, Julien Perez.
Mabel is headquartered in Maastricht, The Netherlands.
Mabel is a psychedelic-based Women’s health platform that focuses on improving mental well-being through mushroom-based supplements.
Mabel is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mabel — Funding & Investors." VCBacked, November 8, 2024, https://www.vcbacked.co/company/mabel. Accessed August 14, 2026.
VCBacked. (2024). Mabel — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/mabel
{{cite web |title=Mabel — Funding & Investors |url=https://www.vcbacked.co/company/mabel |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated